Evidence map›Paper›PMID 36077061›Full record

ArticleInternational journal of molecular sciences2022

Enhancing the Catalytic Activity of Type II L-Asparaginase from

Yawen Zhou, Linshu Jiao, Juan Shen, Huibing Chi, Zhaoxin Lu, Huawei Liu, Fengxia Lu, Ping Zhu

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Towards a dependable data set of structures for L-asparaginase research.Acta crystallographica. Section D, Structural biology · 2024
    Article
  6. Review
  7. Review
  8. Article
  9. Bioengineered Enzymes and Precision Fermentation in the Food Industry.International journal of molecular sciences · 2023
    Review
  10. Improved catalytic performance and molecular insight for lipoxygenase fromFrontiers in bioengineering and biotechnology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yawen ZhouCollege of Food Science and Technology, Nanjing Agricultural University, Nanjing 210095, China.
Linshu JiaoInstitute of Food Safety and Nutrition, Key Lab of Food Quality and Safety of Jiangsu Province-State Key Laboratory Breeding Base, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China.
Juan ShenCollege of Food Science and Technology, Nanjing Agricultural University, Nanjing 210095, China.
Huibing ChiCollege of Food Science and Technology, Nanjing Agricultural University, Nanjing 210095, China.
Zhaoxin LuCollege of Food Science and Technology, Nanjing Agricultural University, Nanjing 210095, China.ORCID 0000-0001-9288-7419
Huawei LiuCollege of Food Science and Technology, Nanjing Agricultural University, Nanjing 210095, China.ORCID 0000-0001-6256-3202
Fengxia LuCollege of Food Science and Technology, Nanjing Agricultural University, Nanjing 210095, China.
Ping ZhuCollege of Food Science and Technology, Nanjing Agricultural University, Nanjing 210095, China.ORCID 0000-0002-4393-7608
Nanjing Agricultural University · CNJiangsu Academy of Agricultural Sciences · CN

Funding

National Natural Science Foundation of China no.31871742
6 · The paper itself

Abstract

Low catalytic activity is a key factor limiting the widespread application of type II L-asparaginase (ASNase) in the food and pharmaceutical industries. In this study, smart libraries were constructed by semi-rational design to improve the catalytic activity of type II ASNase from

Indexed as

AsparaginaseBacillus licheniformisCatalysisMolecular Dynamics SimulationAsparaginasecatalytic efficiencyL-asparaginasemolecular dynamics simulationprotein engineeringsaturation mutagenesis

Identifiers

PMID36077061
PMCPMC9456134
OpenAlexW4293217692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.